A Phase II Trial of Oxaliplatin, Folinic Acid, and 5-Fluorouracil (FOLFOX4) as First-Line Chemotherapy in Advanced Colorectal Cancer: A China Single-Center Experience

Author： Xu Nong   Fang Wei-Jia   Zhang Xiao-Chen   Yu Lan-Fang   Bao Han-Ying   Shi Gen-Ming   Huang Sui   Shen Peng  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.25, Iss.7, 2007-09, pp. : 599-605

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oxaliplatin, 5-fluorouracil and leucovorin (modified FOLFOX-6) as first-line chemotherapy for advanced gastric cancer patients with poor performance status

By                          

Oncology Letters, Vol. 3, Iss. 2, 2012-01 ,pp. : 425-428

Spandidos Publications

Access to resources Recommend Favorite

A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer

By Oh Sung Yong   Kwon Hyuk-Chan   Seo Bong-Gun   Kim Sung-Hyun   Kim Jae-Seok   Kim Hyo-Jin  

Acta Oncologica, Vol. 46, Iss. 3, 2007-01 ,pp. : 336-341

Informa Healthcare

Access to resources Recommend Favorite

Chronotherapy with 5-fluorouracil, folinic acid and carboplatin for metastatic colorectal cancer; an interesting therapeutic index in a phase II trial

By Focan C.   Kreutz F.   Focan-Henrard D.   Moeneclaey N.  

European Journal of Cancer, Vol. 36, Iss. 3, 2000-02 ,pp. : 341-347

Elsevier

Access to resources Recommend Favorite

Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology Group

By Comella Pasquale   Lorusso Vito   Maiorino Luigi   Casaretti Rossana   Cannone Michele   Massidda Bruno   Putzu Carlo   Leo Silvana   Roselli Mario   Mancarella Sergio   Palmeri Sergio   Greco Ettore   Vessia Giacomo   Sandomenico Claudia   Franco Luca  

Cancer Chemotherapy and Pharmacology, Vol. 64, Iss. 5, 2009-10 ,pp. : 893-899

Springer Publishing Company

Access to resources Recommend Favorite

Oxaliplatin/fluorouracil/leucovorin (FOLFOX4 and modified FOLFOX6) in patients with refractory or advanced colorectal cancer: post-approval Japanese population experience

By Shimizu Toshio   Satoh Taroh   Tamura Kenji   Ozaki Tomohiro   Okamoto Isamu   Fukuoka Masahiro   Nakagawa Kazuhiko  

International Journal of Clinical Oncology, Vol. 12, Iss. 3, 2007-06 ,pp. : 218-223

Springer Publishing Company

Access to resources Recommend Favorite